Among recent enforcement actions, the Department of Labor oversaw the restoration of nearly $2 million in 401(k) benefits to the employees of Lange Trucking Inc., a contractor with the U.S. Postal Service.
In addition, the SEC charged Diamond Foods for boosting earnings growth via an accounting scheme to inflate the price of walnuts.
DOL Sees Nearly $2 Million Restored to U.S. Postal Contractors
After an investigation by the Wage and Hour Division of the Department of Labor, Lange Trucking Inc. was on the hook for nearly $2 million in unpaid 401(k) contributions for its employees.
Lange, which had a contract with the U.S. Postal Service that employed 515 drivers, had failed to make the contributions — and had been previously investigated several times by Wage and Hour. It was acquired, subsequent to its violations, by Eagan, Minn.-based Hoovestal Inc., which voluntarily agreed to provide the bulk of the missing benefit contributions — $1.48 million — while Lange itself agreed to provide $500,000.
Top Food Stocks To Buy For 2015: Patterson Companies Inc.(PDCO)
Patterson Companies, Inc. operates as a distributor serving the dental, companion-pet veterinarian, and rehabilitation supply markets in North America. Its Dental Supply segment provides consumable dental supplies, such as x-ray film and solutions; impression and restorative materials; hand instruments; sterilization products; anesthetics; infection control products, including protective clothing, gloves, and facemasks; paper, cotton, and disposable products; toothbrushes; dental accessories; printed office products, office filing supplies, and practice management systems; x-ray machines, handpieces, dental chairs and handpiece control units, diagnostic equipment, dental lights, compressors, chair-side restoration systems, and inter-oral cameras; practice management and clinical software; hardware and networking solutions; and patient education solutions. The company?s Veterinary Supply segment offers consumable supplies, such as lab supplies, paper goods, needles and syr inges, gauze and wound dressings, sutures, latex gloves, and orthopedic and casting products; pharmaceuticals comprising anesthetics, antibiotics, ointments, and nutraceuticals; diagnostics; biologicals, including vaccines and injectibles; and equipment and software. Its Rehabilitation Supply segment provides dressing and grooming devices, and toileting, dining, and bathing aids; braces, splints, and orthotics; exercise bands, putty, weight balls, and mats; walkers, canes, and wheelchair accessories; rolls, wedges, seating and standers, and mobility assistance products; motor stimulation products; products for heating and cooling therapies, electrical stimulation, laser, ultrasound, paraffin, iontophoresis, and therapeutic creams and lotions; and rehabilitation equipment and software. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is based in St. Paul , Minnesota.
Advisors' Opinion:- [By Eric Volkman]
Patterson (NASDAQ: PDCO ) has elected not to raise its quarterly shareholder payout. The company today declared a regular stock dividend of $0.16 per share, to be paid on July 26 to shareholders of record as of July 11. That amount matches the company's previous distribution, which was paid at the end of April. Before that, Patterson handed out $0.14 per share.
- [By Seth Jayson]
Patterson Companies (Nasdaq: PDCO ) reported earnings on May 23. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended April 27 (Q4), Patterson Companies met expectations on revenues and met expectations on earnings per share.
Top 5 Trucking Companies To Buy Right Now: DARA Biosciences Inc.(DARA)
DARA BioSciences, Inc., a development stage biopharmaceutical company, engages in the development and commercialization of oncology treatment and supportive care pharmaceutical products in the United Sates. Its products include Soltamox for the treatment of breast cancer; Gemcitabine for first-line therapy for ovarian, breast, lung and pancreatic cancers; and other cancer support therapeutics, as well as generic sterile injectable cytotoxic products. Its drug development programs include KRN5500, a non-narcotic/non-opioid that has completed Phase IIa clinical trial for the treatment of neuropathic pain in cancer patients; and DB959, which has completed a Phase I study for the treatment of metabolic diseases, including type 2 diabetes and dyslipidemia. The company?s pre-clinical drug candidate includes DB900 PPAR gamma/alpha/delta agonists for development in metabolic and inflammatory diseases; DB160, DPPIV enzyme inhibitors with applications in diabetes, stem cell transpl antation, and cancer therapy; and DB200, Carnitine palmitoyltransferase-1 for skin diseases, including psoriasis. DARA BioSciences, Inc. was incorporated in 2002 and is headquartered in Raleigh, North Carolina.
Advisors' Opinion:- [By John Kell and Lauren Pollock var popups = dojo.query(".socialByline .popC"); ]
Dara Biosciences Inc.(DARA) signed a Medicare Part D prescription drug reimbursement agreement with Wellcare Health Plans Inc.(WCG), providing its Soltamox breast-cancer drug with access to the managed-care company’s extensive network. The pharmaceutical company’s shares rose 19% to $3.45 premarket.
Top 5 Trucking Companies To Buy Right Now: LCA-Vision Inc.(LCAV)
LCA-Vision Inc. provides fixed-site laser vision correction services through its LasikPlus vision centers. Its vision centers offer laser vision correction services for correcting nearsightedness, farsightedness, and astigmatism. As of December 31, 2011, the company operated 53 LasikPlus fixed-site laser vision correction centers located in metropolitan markets in the United States. LCA-Vision Inc. was founded in 1985 and is headquartered in Cincinnati, Ohio.
Advisors' Opinion:- [By Roberto Pedone]
LCA-Vision (LCAV) provides fixed-site laser vision correction services through its LasikPlus vision centers. This stock closed up 4.4% to $4 in Tuesday's trading session.
Tuesday's Range: $3.85-$4.04
52-Week Range: $2.67-$4.60
Tuesday's Volume: 162,000
Three-Month Average Volume: 47,256From a technical perspective, LCAV bounced sharply higher here right above some near-term support levels at $3.75 to $372 with above-average volume. This move is quickly pushing shares of LCAV within range of triggering a major breakout trade. That trade will hit if LCAV manages to take out some near-term overhead resistance levels at $4.04 to $4.26 and then once it takes out its 52-week high at $4.60 with high volume.
Traders should now look for long-biased trades in LCAV as long as it's trending above some key near-term support levels at $3.75 to $3.72 and then once it sustains a move or close above those breakout levels with volume that hits near or above 47,256 shares. If that breakout hits soon, then LCAV will set up to re-test or possibly take out its next major overhead resistance levels at $6.19 to $7.
- [By Lisa Levin]
Medical Practitioners: This industry jumped 2.82% by 10:15 am. The top performer in this industry was LCA-Vision (NASDAQ: LCAV), which rose 2.9%. LCA-Vision's trailing-twelve-month revenue is $91.12 million.
Top 5 Trucking Companies To Buy Right Now: Ishares Silver Trust (SLV)
iShares Silver Trust (the Trust) owns silver transferred to the Trust in exchange for shares issued by the Trust (Shares). Each Share represents a fractional undivided beneficial interest in the net assets of the Trust. The assets of the Trust consist primarily of silver held by the Trust�� custodian on behalf of the Trust. The sponsor of the Trust is iShares Delaware Trust Sponsor LLC (the Sponsor). The trustee of the Trust is The Bank of New York Mellon (the Trustee) and the custodian of the Trust is JPMorgan Chase Bank N.A., London branch (the Custodian).
The activities of the Trust are limited to issuing Baskets of Shares in exchange for the silver deposited with the Custodian as consideration, selling silver as necessary to cover the Sponsor�� fee, Trust expenses not assumed by the Sponsor and other liabilities and delivering silver in exchange for Baskets of Shares surrendered for redemption. Each deposit of silver for the creation of Baskets of Shares and each surrender of Baskets of Shares for the purpose of withdrawing Trust property (including if the trust agreement terminates) must be accompanied by a payment to the Trustee of a fee.
Advisors' Opinion:- [By Quoth the Raven]
In the past I've written countless articles about gold (GLD) and silver (SLV), claiming they're going to be great long-term bets no matter what they currently trade for, and that they're both looking relatively cheap to purchase in 2013 after their prices fell significantly over the past few years. For months, people have informed me that I've looked like an idiot. Now it's starting to look like ole' QTR may have been onto something after all.
- [By Dan Caplinger]
3. Precious metals
As painful as April was for gold and silver, May turned out to be little better. Gold dropped almost 6% in May after losing more than 7% in April, while the corresponding losses for the silver-tracking iShares Silver Trust (NYSEMKT: SLV ) were roughly 9% in May versus 14% the previous month. - [By Tim Iacono]
Silver ETF holdings such as those in the iShares Silver Trust (SLV) have been remarkably resilient amid the recent selling and this indicates still steady domestic demand, but U.S. hedge funds and U.S. futures traders just can't seem to get rid of their precious metals positions fast enough.
- [By Doug Ehrman]
After the U.S. Federal Reserve gave investors a pretty big hint last week that the end of quantitative easing could be in sight, precious metals -- including ETFs SPDR Gold Trust (NYSEMKT: GLD ) and iShares Silver Trust (NYSEMKT: SLV ) -- got hammered. While the short-term outlooks remain murky, the longer-term view is far less certain. A strong dollar and gold prices at their lowest levels in years are giving investors pause, but the picture must be weighed carefully.
No comments:
Post a Comment